Skip to main content

S&P 500 —

Nasdaq-100 —

Dow —

Nasdaq · Common stock

Regeneron Pharmaceuticals (REGN)

$807.67 +$2.65 (+0.33%)

Day’s range
$796.61–$817.17
Volume
418,163

REGN price history

REGN closed at $807.67 on Oct. 26, 2026. Over the past year, its daily close ranged from $585.31 on Oct. 27, 2025 to $852.03 on Sept. 2, 2026.

Source: third-party providers. Daily closing prices, adjusted for stock splits; dividends not included. The price scale runs from $500 to $900, not from zero.
Data table: REGN daily closes, the past year
REGN daily closing prices, Oct. 27, 2025 to Oct. 26, 2026, newest first
DateClose
Oct. 26, 2026$807.67
Oct. 23, 2026$805.02
Oct. 22, 2026$819.09
Oct. 21, 2026$805.67
Oct. 20, 2026$807.48
Oct. 19, 2026$782.04
Oct. 16, 2026$790.74
Oct. 15, 2026$796.34
Oct. 14, 2026$778.36
Oct. 13, 2026$753.12
Oct. 12, 2026$762.81
Oct. 9, 2026$746.54
Oct. 8, 2026$739.57
Oct. 7, 2026$742.12
Oct. 6, 2026$738.72
Oct. 5, 2026$726.47
Oct. 2, 2026$735.20
Oct. 1, 2026$734.81
Sept. 30, 2026$758.27
Sept. 29, 2026$750.51
Sept. 28, 2026$752.25
Sept. 25, 2026$788.04
Sept. 24, 2026$796.02
Sept. 23, 2026$801.82
Sept. 22, 2026$803.90
Sept. 21, 2026$798.17
Sept. 18, 2026$784.85
Sept. 17, 2026$789.45
Sept. 16, 2026$774.61
Sept. 15, 2026$774.11
Sept. 14, 2026$793.74
Sept. 11, 2026$781.49
Sept. 10, 2026$793.26
Sept. 9, 2026$807.65
Sept. 8, 2026$810.31
Sept. 4, 2026$827.72
Sept. 3, 2026$843.47
Sept. 2, 2026$852.03
Sept. 1, 2026$823.82
Aug. 31, 2026$799.08
Aug. 28, 2026$794.19
Aug. 27, 2026$807.71
Aug. 26, 2026$814.79
Aug. 25, 2026$833.56
Aug. 24, 2026$828.50
Aug. 21, 2026$834.04
Aug. 20, 2026$826.64
Aug. 19, 2026$840.84
Aug. 18, 2026$810.24
Aug. 17, 2026$805.93
Aug. 14, 2026$803.48
Aug. 13, 2026$805.97
Aug. 12, 2026$797.99
Aug. 11, 2026$797.00
Aug. 10, 2026$808.05
Aug. 7, 2026$784.36
Aug. 6, 2026$772.11
Aug. 5, 2026$768.58
Aug. 4, 2026$760.66
Aug. 3, 2026$759.24
July 31, 2026$762.63
July 30, 2026$738.34
July 29, 2026$695.42
July 28, 2026$695.18
July 27, 2026$667.17
July 24, 2026$656.01
July 23, 2026$651.91
July 22, 2026$651.18
July 21, 2026$675.19
July 20, 2026$672.15
July 17, 2026$676.69
July 16, 2026$678.94
July 15, 2026$664.45
July 14, 2026$656.12
July 13, 2026$663.09
July 10, 2026$664.52
July 9, 2026$667.95
July 8, 2026$662.88
July 7, 2026$676.23
July 6, 2026$649.81
July 2, 2026$654.27
July 1, 2026$624.72
June 30, 2026$623.54
June 29, 2026$631.81
June 26, 2026$632.90
June 25, 2026$620.14
June 24, 2026$623.43
June 23, 2026$618.03
June 22, 2026$612.50
June 18, 2026$609.94
June 17, 2026$607.93
June 16, 2026$614.73
June 15, 2026$614.98
June 12, 2026$612.14
June 11, 2026$611.48
June 10, 2026$601.65
June 9, 2026$616.18
June 8, 2026$611.34
June 5, 2026$635.45
June 4, 2026$628.73
June 3, 2026$618.95
June 2, 2026$602.92
June 1, 2026$600.66
May 29, 2026$614.78
May 28, 2026$621.52
May 27, 2026$627.74
May 26, 2026$634.62
May 22, 2026$638.88
May 21, 2026$642.59
May 20, 2026$649.76
May 19, 2026$630.30
May 18, 2026$629.68
May 15, 2026$698.25
May 14, 2026$712.87
May 13, 2026$719.88
May 12, 2026$723.41
May 11, 2026$712.77
May 8, 2026$714.89
May 7, 2026$709.10
May 6, 2026$721.05
May 5, 2026$702.27
May 4, 2026$709.21
May 1, 2026$701.42
April 30, 2026$707.06
April 29, 2026$686.36
April 28, 2026$731.77
April 27, 2026$744.44
April 24, 2026$751.57
April 23, 2026$766.02
April 22, 2026$746.58
April 21, 2026$747.36
April 20, 2026$749.41
April 17, 2026$750.57
April 16, 2026$746.00
April 15, 2026$753.93
April 14, 2026$755.51
April 13, 2026$746.46
April 10, 2026$748.87
April 9, 2026$767.85
April 8, 2026$775.53
April 7, 2026$760.27
April 6, 2026$763.04
April 2, 2026$761.85
April 1, 2026$777.25
March 31, 2026$772.64
March 30, 2026$749.29
March 27, 2026$737.71
March 26, 2026$756.73
March 25, 2026$749.47
March 24, 2026$741.69
March 23, 2026$736.53
March 20, 2026$732.87
March 19, 2026$737.45
March 18, 2026$744.12
March 17, 2026$759.05
March 16, 2026$756.91
March 13, 2026$745.77
March 12, 2026$746.61
March 11, 2026$774.66
March 10, 2026$772.03
March 9, 2026$781.60
March 6, 2026$759.86
March 5, 2026$764.93
March 4, 2026$787.50
March 3, 2026$766.66
March 2, 2026$790.81
Feb. 27, 2026$781.67
Feb. 26, 2026$770.79
Feb. 25, 2026$784.28
Feb. 24, 2026$772.19
Feb. 23, 2026$787.04
Feb. 20, 2026$779.67
Feb. 19, 2026$782.38
Feb. 18, 2026$792.16
Feb. 17, 2026$793.53
Feb. 13, 2026$803.17
Feb. 12, 2026$783.65
Feb. 11, 2026$778.97
Feb. 10, 2026$754.91
Feb. 9, 2026$780.28
Feb. 6, 2026$785.51
Feb. 5, 2026$766.63
Feb. 4, 2026$775.06
Feb. 3, 2026$759.18
Feb. 2, 2026$755.02
Jan. 30, 2026$741.45
Jan. 29, 2026$749.44
Jan. 28, 2026$751.13
Jan. 27, 2026$771.25
Jan. 26, 2026$762.65
Jan. 23, 2026$753.55
Jan. 22, 2026$755.51
Jan. 21, 2026$749.33
Jan. 20, 2026$733.78
Jan. 16, 2026$733.04
Jan. 15, 2026$741.92
Jan. 14, 2026$754.14
Jan. 13, 2026$758.91
Jan. 12, 2026$768.00
Jan. 9, 2026$796.55
Jan. 8, 2026$801.01
Jan. 7, 2026$812.27
Jan. 6, 2026$776.54
Jan. 5, 2026$763.23
Jan. 2, 2026$776.31
Dec. 31, 2025$771.87
Dec. 30, 2025$773.94
Dec. 29, 2025$780.50
Dec. 26, 2025$784.97
Dec. 24, 2025$783.71
Dec. 23, 2025$785.17
Dec. 22, 2025$779.36
Dec. 19, 2025$767.96
Dec. 18, 2025$748.71
Dec. 17, 2025$749.79
Dec. 16, 2025$746.36
Dec. 15, 2025$752.62
Dec. 12, 2025$741.29
Dec. 11, 2025$746.80
Dec. 10, 2025$726.21
Dec. 9, 2025$692.58
Dec. 8, 2025$703.26
Dec. 5, 2025$718.36
Dec. 4, 2025$722.80
Dec. 3, 2025$723.67
Dec. 2, 2025$742.00
Dec. 1, 2025$750.11
Nov. 28, 2025$780.19
Nov. 26, 2025$784.61
Nov. 25, 2025$787.32
Nov. 24, 2025$761.45
Nov. 21, 2025$755.90
Nov. 20, 2025$737.00
Nov. 19, 2025$702.75
Nov. 18, 2025$725.34
Nov. 17, 2025$704.31
Nov. 14, 2025$693.50
Nov. 13, 2025$694.99
Nov. 12, 2025$681.72
Nov. 11, 2025$674.55
Nov. 10, 2025$654.74
Nov. 7, 2025$657.53
Nov. 6, 2025$646.87
Nov. 5, 2025$644.19
Nov. 4, 2025$628.00
Nov. 3, 2025$642.25
Oct. 31, 2025$651.80
Oct. 30, 2025$654.04
Oct. 29, 2025$652.91
Oct. 28, 2025$654.48
Oct. 27, 2025$585.31

Key figures

52-week range
$577.95–$852.03Low Oct. 24, 2025; high Sept. 2, 2026
Average daily volume
725,284Past 3 months
Market value
$81.69B
Dividend yield
0.46%Past 12 months of regular dividends
From 52-week high
−5.21%

Price change

1 month
+2.49%
3 months
+23.12%
Year to date
+4.64%
1 year
+39.75%

$1,000 a year ago

$1,000 put into REGN at the close on Oct. 24, 2025 would be worth $1,397.

Price only, dividends not included.

What Wall Street says about REGN

In the past 90 days, Wall Street firms published 19 rating or price-target actions on REGN: 2 upgrades, 1 reiterated rating and 16 raised price targets.

Rating and price-target actions on REGN, past 90 days
ActionRating
TD CowenRaises targetBuy$960 to $980
Piper SandlerRaises targetOverweight$854 to $865
UBSUpgradeNeutral to Buy$660 to $978
RBC CapitalRaises targetSector perform$737 to $810
Morgan StanleyRaises targetEqual-weight$758 to $779
Truist SecuritiesRaises targetBuy$772 to $780
JP MorganRaises targetOverweight$900 to $950
Argus ResearchUpgradeHold to Buy$850
JefferiesRaises targetBuy$870 to $930
RBC CapitalReiteratesSector perform$737
HSBCRaises targetBuy$800 to $920
Leerink PartnersRaises targetMarket perform$641 to $824
CitigroupRaises targetNeutral$700 to $740
GuggenheimRaises targetBuy$1,000 to $1,030
Cantor FitzgeraldRaises targetOverweight$750 to $795
Morgan StanleyRaises targetEqual-weight$730 to $758
RBC CapitalRaises targetSector perform$696 to $737
Truist SecuritiesRaises targetBuy$769 to $772
Wells FargoRaises targetEqual-weight$700 to $750

Ratings and price targets are the firms’ own opinions, reported as published.

Not investment advice.

Recent dividends

Cash dividends on REGN, newest first
Ex-dividend datePer share
Regular, paid Aug. 31$0.94
Regular, paid June 4$0.94
Regular, paid March 5$0.94
Regular, paid Dec. 5, 2025$0.88

About Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; Kevzara in rheumatoid arthritis; and Lynozyfic for multiple myeloma. Regeneron has multiple partnerships and collaboration agreements, with Sanofi (Dupixent, others) and Bayer (Eylea) as its largest partners.

Headquarters
Tarrytown, N.Y.
Employees
15,410
Listed
April 2, 1991
Sector
Health care
Industry
Pharmaceutical preparations

regeneron.com, the company’s website

In WallStreetDigest editions

No WallStreetDigest article about REGN is on the site yet.

  • LLYEli Lilly & Co.
  • JNJJohnson & Johnson
  • ABBVABBVIE INC.
  • MRKMerck & Co., Inc.
  • ABTAbbott Laboratories
  • PFEPfizer Inc.